SCHEMBL4762569

SCHEMBL4762569

COc1cccc(-c2c(OC(=O)NCCN3CCOCC3)[nH]c3ccc(S(=O)(=O)Nc4ccc(C(C)(C)C)cc4)cc23)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
KMT2A Q03164 3/20 0.41
BACE1 P56817 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
EPHX2 P34913 1/20 0.39
GALR3 O60755 1/20 0.39
BCL2 P10415 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3949921 0.96 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL4760543 0.92 ALDH1A1 (0.47) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL4762845 0.91 ALDH1A1 (0.46) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL5152014 0.89 CYP2C9 (0.58) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL3947463 0.88 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL3951927 0.88 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL3941985 0.88 ALDH1A1 (0.46) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL3940688 0.87 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL3944430 0.87 ALDH1A1 (0.46) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL3942349 0.86 CYP1A2 (0.44) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001843-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP claimed
WO-2007107384-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-09-27 WO claimed
EP-2001843-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed
WO-2007107384-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-09-27 WO disclosed